The Muscular Dystrophy Association (MDA) announced the formation of its formal Medical Advisory Team who provide MDA with strategic guidance on issues that impact research and clinical care for people living with muscular dystrophy, amyotrophic lateral sclerosis (ALS) and related neuromuscular disorders – more than 43 diseases. Each of the team members is a leading clinician at an MDA Care Center and is an internationally known expert in muscular dystrophy, ALS and related neuromuscular diseases. The MDA Care Center network spans over 150 locations at the nation’s top medical institutions.
Dr. Barry Byrne, associate chair of pediatrics and director of the Powell Gene Therapy Center at the University of Florida, will serve as chief medical advisor for the team. Dr. Byrne is an ardent supporter of newborn screening and has been an innovator and early adopter of new FDA-approved therapies that have the potential to alter the course of some neuromuscular disorders. He was the first physician to administer an approved gene therapy to a neuromuscular patient in the U.S.Learn more about UF Researcher Among Muscular Dystrophy Association Strategic Medical Advisory Team.